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Studies involving antimicrobial-coated endotracheal tubes are scarce, and new
approaches to control multidrug-resistant Pseudomonas aeruginosa biofilm on these
devices should be investigated. In this study, five new P. aeruginosa bacteriophages
from domestic sewage were isolated. All of them belong to the order Caudovirales,
Myoviridae family. They are pH and heat stable and produce 27 to 46 particles after a
latent period of 30 min at 37◦C. Their dsDNA genome (ranging from ∼62 to ∼65 kb)
encodes 65 to 89 different putative proteins. They exhibit a broad lytic spectrum and
infect 69.7% of the P. aeruginosa strains tested. All the bacteriophages were able to
reduce the growth of P. aeruginosa strains in planktonic form. The bacteriophages were
also able to reduce the biofilm viability rates and the metabolic activity of P. aeruginosa
strains in a model of biofilms associated with endotracheal tubes. In addition, scanning
electron microscopy micrographs showed disrupted biofilms and cell debris after
treatment of bacteriophages, revealing remarkable biofilm reduction. The lytic activity
on multidrug-resistant P. aeruginosa biofilm indicates that the isolated bacteriophages
might be considered as good candidates for therapeutic studies and for the application
of bacteriophage-encoded products.
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INTRODUCTION
Mechanical ventilation through an endotracheal or tracheostomy tube is a supportive intervention
to critically ill patients and represents a risk factor for the occurrence of ventilator-associated
pneumonia (VAP; Haas et al., 2014). VAP is the most common healthcare-associated infection in
critically ill patients, involves high financial costs, and has negative prognosis (Barbier et al., 2013;
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Zimlichman et al., 2013; Russotto et al., 2015). VAP etiologies
have been widely discussed, and the factors associated with
its development include endotracheal tube biofilm formation
which plays an important role as a reservoir for microorganisms
(Nseir et al., 2011).
Knowing the potential risk factor of multidrug-resistant
Pseudomonas aeruginosa biofilms on endotracheal tubes, interest
in the development of antimicrobial-coated endotracheal tubes
has emerged. The presence of antimicrobial agents, such as silver
particles and chlorhexidine, on the surface of endotracheal tubes
demonstrated a decrease in biofilm formation on the device
surface’s (Berra et al., 2004; Tokmaji et al., 2015). However,
chemical compounds have been implicated in bacterial resistance
(Cieplik et al., 2019) and frequently linked to potential cytotoxic
hazards (Lessa et al., 2010; Mao et al., 2018). Therefore, new
approaches to control multidrug-resistant P. aeruginosa biofilm
on endotracheal tubes should be investigated.
The applicability of bacteriophages in medical devices has
aroused interest in several areas, including infections related
to the urinary tract (Nzakizwanayo et al., 2015; Melo et al.,
2016), venous catheters (Lungren et al., 2014), and orthopedic
prostheses (Kaur et al., 2014; Barros et al., 2020). Recently,
new lytic bacteriophages able to control multidrug-resistant
P. aeruginosa planktonic cells and associated-biofilm forms were
described (Yuan et al., 2019; Adnan et al., 2020). Although
promising, there are few reports on bacteriophage applicability
to control biofilms associated with endotracheal tubes (Aleshkin
et al., 2016). Thus, we consider it essential to clarify whether
newly isolated bacteriophages can be applied in order to
control P. aeruginosa biofilms on the surface of endotracheal
tubes. The null hypothesis of this study is that there would
not be a difference in P. aeruginosa growth when challenged
with bacteriophages.
MATERIALS AND METHODS
Bacteriophage Isolation and Propagation
Bacteriophages were isolated from domestic sewage, and
P. aeruginosa (ATCC 27853) was used as the host strain.
Isolation, sample enrichment, and purification methods followed
the protocol described previously (Sillankorva et al., 2008).
Briefly, 20 ml of domestic effluents, collected from March to
November 2018 (Domestic Sewage Treatment Station, Ribeirão
Preto, Brazil and Araxá, Brazil), was mixed to 20 ml of
double-strength tryptic soy broth (TSB; BD Difco, Sparks, MN,
United States) and 100 µl of exponentially grown P. aeruginosa.
The presence of bacteriophage was confirmed by inhibition
haloes on double-layer agar plating [Tryptic Soy Agar Soft
(0.8% agar)—TSAS (BD Difco)] (Sambrook and Russell, 2001).
Repeated double-layer agar plating was done until single-
plaque morphology was observed. For propagation, one isolated
plaque was collected through a sterile toothpick and diluted
in 25 µl of elution buffer [1 M Tris–HCl, pH 7.5 (Sigma
Aldrich, Saint Louis, MO, United States), 10 mM MgSO4
(Sigma Aldrich), 10 mM NaCl (Dinâmica, Indaiatuba, SP,
Brazil), 0.002% (w/v) gelatin (Dinâmica)]. The suspension was
dropped onto a TSAS medium, with P. aeruginosa lawns, and
incubated at 37◦C for 24 h. Afterward, 10 ml of elution buffer
was added to each plate to elute the bacteriophages, which
were purified with chloroform (Sigma Aldrich), titrated, and
stored at 4◦C.
Transmission Electron Microscopy
One milliliter of bacteriophage suspension was centrifuged at
21,800 g for 60 min at 4◦C. The sediment was washed twice
in sterile ultrapure water, and 25 µl of each bacteriophage
was applied on an electron microscopy grid. The grids were
stained with 2% uranyl acetate for 5 min and then analyzed
by transmission electron microscopy (JEOL JEM-100 CXII
Akishima, Tokyo, Japan; Melo et al., 2014).
Acid–Base and Thermal Stability
In order to assess acid–base stability, 100 µl of the bacteriophage
suspension (108 plaque forming units per milliliter—PFU/ml)
were added to 900 µl of elution buffer, with pH adjusted to 3.0,
5.0, 7.0, 9.0, and 11.0. The samples were incubated for 2 h at
37◦C. To evaluate thermal stability, 100 µl of the bacteriophage
suspension (108 PFU/ml) was added to 900 µl of elution buffer
and incubated at different temperatures (37, 42, 50, 60, 70, and
80◦C) for 2 h (20). After the incubation period, the phage titer
was determined through the double-layer agar method (Cui
et al., 2017). The assays were carried out at three independent
times in triplicate.
One-Step Growth Curve
An exponential-phase P. aeruginosa culture was centrifuged at
4,200 g for 5 min, and OD600 was adjusted to achieve ∼1011
colony-forming units per milliliter (CFU/ml). Subsequently, 5 ml
of bacteria suspension was added to 5 ml of bacteriophage
suspension at 5 × 108 PFU/ml (multiplicity of infection—MOI:
0.005). The mixture was incubated (120 rpm, 37◦C, 5 min) and
centrifuged (4,200 g, 5 min), and 10 ml of sterile TSB was added to
the pellet. Samples were incubated (120 rpm, 37◦C), and aliquots
were taken every 5 min until 60 min post-infection. Using the
double-layer agar plating, the number of bacteriophage particles
was determined at each time. Latent period was determined as the
time required for the phage to increase in number and burst size
as the ratio between the number of bacteriophages after reaching
the plateau and the number of infected bacteria (Sillankorva et al.,
2008). The assay was carried out at three independent times.
Genome Sequencing Analysis
One milliliter of bacteriophage stock was incubated with
10 U DNAse I (Sigma Aldrich) and 10 µl RNAse A
(20 mg/ml; Sigma Aldrich) at 37◦C for 1 h. Enzymes were
inactivated at 70◦C for 15 min. Then, the suspensions were
incubated with extraction buffer [40 µl EDTA 0.5 M (Sigma
Aldrich), 5 µl proteinase K 10 mg/ml (Sigma Aldrich),
and 50 µl SDS 10% (w/v; Sigma Aldrich)]. Extraction was
performed with phenol/chloroform/isoamyl alcohol (25:24:1;
Sigma Aldrich). Absence of bacterial contaminant DNA was
confirmed by amplification of the 16S rRNA P. aeruginosa gene
(Spilker et al., 2004).
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Libraries were prepared using the NexteraXT kit
(Illumina, San Diego, CA, United States), and genomes
were sequenced using Illumina MiSeq paired-end sequencing
(2 × 300 bp/coverage 100×), according to the manufacturer’s
instructions. Reads were trimmed and assembled into a single
contig using Velvet de novo tool (Illumina). Potential coding
sequences (CDSs) were initially annotated using myRAST (Aziz
et al., 2008), and alternative start codons or non-annotated
CDSs were further analyzed using Geneious version 2019.2.1
(Biomatters Ltd., Auckland, New Zealand). Encoded proteins
were queried against the National Center for Biotechnology
Information (NCBI) non-redundant database with BLASTP
(coverage > 80%; E-value ≤ 10−5; Altschul et al., 1990).
Protein families, signatures, and structure prediction were
searched with PFAM (Finn et al., 2014), InterPro (Finn et al.,
2017), and HHpred (Söding, 2005), while the presence of
transmembrane domains was checked using TMHMM (Käll
and Sonnhammer, 2002), and Phobius (Käll et al., 2004).
To predict signal peptide cleavage sites, SignalP (Petersen
et al., 2011), and Spoctopus (Viklund et al., 2008) were used.
Transfer RNAs (tRNAs) were scanned using tRNAscan-SE
(Schattner et al., 2005).
Host Range Investigation and EOP
Analysis
Host range was evaluated by the presence of clear or turbid
inhibition haloes in a spot test on double-layer agar against
26 clinical isolates and seven multidrug-resistant P. aeruginosa
strains (Panel ATCC R© MP-23TM; Table 1). The susceptibility
profile of clinical isolates was determined by the disk diffusion
method. Susceptibility test, antimicrobial classes, antibiotic
concentration, and zone diameter breakpoint for P. aeruginosa
strains were defined according to the Clinical and Laboratory
Standards Institute (Clinical and Laboratory Standards Institute
[CLSI], 2019).
Efficiency of plating (EOP) was determined for all
P. aeruginosa strains positive for bacteriophage lytic activity.
Tenfold dilutions of the bacteriophages were spotted on double-
layer agar inoculated with P. aeruginosa strains. EOP values
were calculated as the ratio between the lysis plaques produced
in each susceptible strain and the number of plaques produced
in P. aeruginosa ATCC 27853. EOP was recorded as high, low,
and inefficient, representing >1, 0.1–1, and <0.1%, respectively
(Melo et al., 2014).
Infection of Planktonic Cells
Ten clinical isolates with the highest EOP values, P. aeruginosa
ATCC 27853, and multidrug-resistant P. aeruginosa ATCC 2108,
ATCC 2110, ATCC 2112, and ATCC 2113 were selected for this
assay. Then, 100 µl of P. aeruginosa strains, OD600 adjusted
to achieve ∼109 CFU/ml, was inoculated with 100 µl of each
bacteriophage at a concentration of 5× 107 PFU/ml (MOI: 0.05).
The positive and negative control experiments were performed
using a dilution buffer instead of bacteriophages and sterile TSB
instead of bacterial suspension, respectively. The plates were
incubated at 37◦C, 80 rpm. The OD600 was measured after 2, 4,
6, 8, and 24 h (Melo et al., 2014). The assays were carried out at
three independent times in triplicate.
Antibiofilm Activity Measurement
The same 15 P. aeruginosa strains applied in the infection
of planktonic cells test were selected for this assay. The anti-
biofilm activity of the bacteriophages was determined by means
of biofilm viability rates (CFU/cm2), metabolic activity of the
bacteria (XTT), and scanning electron microscopy (SEM). The
assays were carried out at three independent times in triplicate.
For biofilm infection, strains were grown in TSB medium
(37◦C, 24 h), and OD600 was adjusted to ∼109 CFU/ml.
Circular endotracheal tube specimens (Ø 5 mm; Rüsh, Meridian,
MS, United States) were sterilized by hydrogen peroxide
plasma (Sterrad 100S, Irvine, CA, United States) and randomly
distributed in 48-well tissue culture plates. Each well received
400 µl of TSB medium containing the standardized cell
suspension (∼107 CFU/ml). Negative control was performed
using sterile TSB. The plates were incubated for 48 h at 37◦C
and 80 rpm. Afterward, the specimens were removed carefully
from the plate, rinsed in 10 ml of phosphate-buffered saline
(PBS), and transferred to a new plate with 1 ml of sterile culture
medium and 108 PFU/ml of bacteriophages. The control samples
received culture medium without bacteriophages. The plates were
incubated for 24 h at 37◦C and 80 rpm. After the incubation time,
the specimens were removed from the wells through sterilized
tweezers and rinsed in 10 ml of PBS.
For CFU quantification, the specimens were transferred to a
tube containing 2 ml of PBS. In order to detach the remaining
biofilm, the tubes were vortexed for 30 s, sonicated (200 W,
40 kHz; Altsonic, Clean 9CA, Ribeirão Preto, SP, Brazil) for
20 min, and vortexed again for 2 min. Afterward, 10-fold-dilution
aliquots (100–10−6) were seeded in Petri dishes containing TSA
medium. The Petri dishes were incubated at 37◦C for 24 h,
and the number of colonies was registered and expressed as
log CFU/cm2.
For the evaluation of metabolic activity, the specimens were
transferred to another 48-well plate containing 316 µl PBS
supplemented with 100 mM glucose (Sigma Aldrich), 80 µl XTT
1 mg/ml (Sigma Aldrich), and 4 µl of 0.4 mM menadione (Sigma
Aldrich). The plates were statically incubated, protected from
light, at 37◦C for 2 h, and the absorbance of the resulting solution
was measured (492 nm).
For SEM, P. aeruginosa ATCC 27853 was analyzed. The
biofilms were removed from the plates and washed twice in
distilled water. Samples were fixed with 2.5% glutaraldehyde for
60 min and then dehydrated in a graded ethanol series (30, 50,
70, 90, and 100%). After chemical drying (hexamethyldisilazane;
Sigma Aldrich), the specimens were mounted on a metal
stub and gold-coated. The surface morphology of the biofilms
was examined under high vacuum with a JEOL JSM-35CF
microscope (Tokyo, Japan).
Statistical Analysis
Statistical tests were performed through the IBM SPSS Statistics
25.0 software (IBM Corp Armonk, NY, United States). The
significance level was set to 0.05. All data showed normal



















TABLE 1 | Lytic spectrum and efficiency of plating of the bacteriophages against sensible and multidrug-resistant Pseudomonas aeruginosa isolated from different sources.
Isolates Source Antibiotic resistancea vB_PaeM_USP_1 vB_PaeM_USP_2 vB_PaeM_USP_3 vB_PaeM_USP_18 vB_PaeM_USP_25
Infectivity EOPb Infectivity EOPb Infectivity EOPb Infectivity EOPb Infectivity EOPb
Sa_ATCC 6538 − − − − −
Ec_ATCC 25927 − − − − −
Ef_ATCC 29212 − − − − −
Pa_ATCC 27853 Blood S + + + + +
Pa_ATCC 2108c Sputum AMK, CFZ, CTX, GEN, IMP, TGC + High + High + High + Inefficient + Inefficient
Pa_ATCC 2109c Sputum AMK, CFZ, TGC − − − − −
Pa_ATCC 2110c Sputum AMP, CFZ, CTX, FOX, NIT, TGC, SXT + Low + High + High + Low + Low
Pa_ATCC 2111c Sputum AMC, AMP, CFZ, CPD, CRO, CTX, CXM,
FOX, NIT, TET, TGC, SXT
− − − − −
Pa_ATCC 2112c Sputum AMC, AMP, CFZ, CPD, CRO, CTX, CXM,
FOX, NIT, TET, TGC, SXT
+ High + High + High + Low + Low
Pa_ATCC 2113c Sputum AMP, AMC, CFZ, CTX, NIT, SAM, SXT + High + High + Low + Inefficient + Inefficient
Pa_ATCC 2114c Sputum AMP, AMC, CFZ, CTX, NIT, SAM, TZP, SXT − − − − −
Pa_Ba_3 Prosthetic biofilm S − − − − −
Pa_Ba_129 Prosthetic biofilm S + Inefficient + Inefficient + Inefficient + Inefficient + Inefficient
Pa_Ba_130 Prosthetic biofilm S + Inefficient + Inefficient + Inefficient + Inefficient + Inefficient
Pa_Ba_164 Prosthetic biofilm S + High + High + High + High + High
Pa_Ba_168 Prosthetic biofilm S + Low + High + High + High + High
Pa_Ba_169 Prosthetic biofilm S + High + High + High + High + High
Pa_Ba_286 Prosthetic biofilm S + Inefficient + Inefficient + Inefficient + Inefficient + Inefficient
Pa_Fe_39 Saliva S − − − − −
Pa_Mi_1 Blood S + Low + Low + Low + Low + Low
Pa_Mi_2 Sputum S + High + Low + High + High + Low
Pa_Mi_3c Urine CIP, GEN, IMP, LVX + Inefficient + Inefficient + Inefficient + Inefficient + Inefficient
Pa_Mi_4 Urine S − − − − −
Pa_Mi_5 Sputum S + Inefficient + Inefficient + Inefficient + Inefficient + Inefficient
Pa_Mi_6 Urine S + High + Low + Low + High + High
Pa_Mi_7 Sputum S + Low + High + High + High + Low
Pa_Trac_3 Tracheal secretion S − − − − −
Pa_Trac_4 Tracheal secretion S − − − − −
Pa_Trac_5c Tracheal secretion AMK, FEP, CIP, GEN, IMP, LVX, MEM − − − − −
Pa_Trac_14c Tracheal secretion AMK, CIP, IMP, LVX, MEM + High + High + Inefficient + Inefficient + Inefficient
Pa_Trac_20 Tracheal secretion S + High + High + High + High + High
Pa_Trac_22 Tracheal secretion S + Inefficient + Inefficient + Inefficient + Inefficient + Inefficient
Pa_Trac_23 Tracheal secretion S + High + High + High + Low + Low
Pa_Trac_27c Tracheal secretion AMK, CIP, GEN, IMP, LVX, MEM + High + High + High + Inefficient + Inefficient
Pa_Trac_31 Tracheal secretion S − − − − −
Pa_Ren_1 Saliva S + High + High + High + High + High
Pa_Gus_B2 Blood S + High + High + High + Inefficient + Inefficient
aAMC, amoxicillin-clavulanic acid; AMK, amikacin; AMP, ampicillin; CFZ, cefazolin; CIP, ciprofloxacin; CPD, cefpodoxime; CRO, ceftriaxone; CTX, cefotaxime; CXM, cefuroxime; FEP, cefepime; FOX, cefoxitin; GEN,
gentamicin; IMP, imipenem; LVX, levofloxacin; MEM, meropenem; NIT, nitrofurantoin; SAM, ampicillin-sulbactam; SXT, trimethoprim-sulfamethoxazole; TET, tetracycline; TGC, tigecycline; and TZP, piperacillin-tazobactam.
bEOP (efficiency of plating) was recorded as high, low, and inefficient, representing >1, 0.1–1, and <0.1%, respectively. cMDR, multidrug-resistant (defined as acquired non-susceptibility to at least one agent in three
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distribution and homogeneous variance and were analyzed
using two-way ANOVA, with independent levels and Bonferroni
post hoc test.
RESULTS
Bacteriophage Isolation and Propagation
Five new lytic bacteriophages against P. aeruginosa were isolated
from domestic sewage and designated as vB_PaeM_USP_1,
vB_PaeM_USP_2, vB_PaeM_USP_3, vB_PaeM_USP_18, and
vB_PaeM_USP_25. All bacteriophages were able to form clear
plaques, having well-defined boundaries. It was observed that
none of the bacteriophages produced double haloes, and it was
not possible to differentiate lysis plaques among the different
isolated bacteriophages (Figures 1A–E).
Electron Microscopy
The morphological aspects were slightly different among
the different isolated viruses (Figures 1F–J). According to
the International Committee on Taxonomy of Viruses, all
bacteriophages belong to the order Caudovirales and are
members of the Myoviridae family.
Acid–Base and Thermal Stability
The values of pH 3.0 and pH 11.0 contributed to reduced
bacteriophage viability (p < 0.05). Neutral pH (7.0) and small
variations in hydrogenionic potential (pH 5.0 and pH 9.0)
did not cause significant changes in viability. vB_PaeM_USP_2
and vB_PaeM_USP_3 were the most resistant to pH variation
(Figure 2A). Reduced bacteriophage viability after exposure to 70
and 80◦C was noticed. Bacteriophage vB_PaeM_USP_25 was the
most resistant to temperature variation (Figure 2B).
One-Step Growth Curve
A one-step growth curve revealed a similar behavior among the
bacteriophages (Supplementary Figure 1). Latent period and
yields at burst size are presented in Figure 1K.
Genome Sequencing Analysis
The complete genome sequence of each bacteriophage was
deposited in the NCBI database under the accession numbers
MT491204–MT491208. Genome analysis revealed that the
five bacteriophages are potentially virulent since they do
not encode for any known protein associated to lysogeny.
Moreover, no known virulence-associated or toxic proteins
were identified, revealing that the isolated bacteriophages are
potentially safe for therapeutic purposes. All bacteriophage
genomes are composed of double-stranded DNA molecules,
and no putative genes coding for tRNAs were found. The
general genomic properties of the five bacteriophages are
presented in Table 2. Two different subgroups of bacteriophages
could be observed (Figure 3). The first one, composed
of bacteriophages vB_PaeM_USP_1, vB_PaeM_USP_2, and
vB_PaeM_USP_3, presents similar genome sizes (approximately
65 kb), G + C content (approximately 55.5%), a high
nucleotide pairwise identity (94.6%), and proteome homology
(sharing 83 protein homologs between them), with roughly
62% of the proteins with unknown function (Figure 3).
Despite their similarity, they present some differences at
the beginning (0–5 kb) and at the end of their genome
(53 kb end; Figure 4A). Their genomes share high nucleotide
identity with other P. aeruginosa bacteriophage members of the
Pbunavirus genus, namely, Pseudomonas virus Pa193, Epa22,
vB_PaeM_PAO1_Ab27, and BrSP1, with identities above 96%
and coverages of up to 98%.
FIGURE 1 | (A–E) Representative image of phage isolates depicting different plaque morphologies of vB_PaeM_USP_1, vB_PaeM_USP_2, vB_PaeM_USP_3,
vB_PaeM_USP_18, and vB_PaeM_USP_25. (F–J) Transmission electron micrographs of individual bacteriophages. (K) Panel of plaque characteristics, phage
morphology, latent period, and burst size.
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FIGURE 2 | Effects of different pH and temperature values (log10UFP/ml) on vB_PaeM_USP_1, vB_PaeM_USP_2, vB_PaeM_USP_3, vB_PaeM_USP_18, and
vB_PaeM_USP_25.
TABLE 2 | Genomic properties of Pseudomonas aeruginosa bacteriophages.
Phage Accession number Genome size (bp) GC% CDSs Unknown proteins Genus
vB_PaeM_USP_1 MT491204 65,918 55.6 87 54 Pbunavirus
vB_PaeM_USP_2 MT491205 65,606 55.5 86 53 Pbunavirus
vB_PaeM_USP_3 MT491206 65,567 55.5 89 56 Pbunavirus
vB_PaeM_USP_18 MT491207 63,030 63.7 65 48 Unknown
vB_PaeM_USP_25 MT491208 62,537 63.6 66 49 Unknown
The second subgroup, composed of vB_PaeM_USP_18 and
vB_PaeM_USP_25, has nucleotide pairwise identity of 97.1%
and shares 65 homologs, ca. 74% of them without an assigned
function (Figure 3). A slightly lower homology is observed in
the genomic regions 3–4.5, 12.5–14, and mainly from 39–46.5 kb
(Figure 4B). The low homology with genomes from other phages
deposited with the NCBI does not allow grouping these phage
genomes with any known genus or subfamily.
Host Range Investigation and EOP
Analysis
All five bacteriophages exhibited a broad lytic spectrum and were
able to infect 69.7% (n = 23) of the P. aeruginosa strains, of which
seven were multidrug resistant. Furthermore, the bacteriophages
showed lytic activity on clinical strains isolated from different
infection sites (Table 1).
The EOP values of vB_PaeM_USP_1 (high: 13; insufficient: 6;
low: 4), vB_PaeM_USP_2 (high: 14; insufficient: 6; low: 3), and
vB_PaeM_USP_3 (high: 13; insufficient: 7; low: 3) were higher
than vB_PaeM_USP_18 (high: 8; insufficient: 11; low: 4) and
vB_PaeM_USP_25 (high: 6; insufficient: 11; low: 6). The last two
viruses had low or inefficient EOP for all multidrug-resistant
strains (Table 1). Although during host range investigation the
bacteriophages had lysed the same strains, inefficient EOP results
indicate that the haloes observed previously refer to “lysis from
without events.”
Infection of Planktonic Cells
All five bacteriophages reduced bacterial growth up to 8 h of
incubation in 13 strains (p < 0.05; Figure 5A). The reduction
was above 60% after 6 and 8 h of incubation. After 24 h of
incubation, all bacteriophages were able to maintain lower OD
values in three strains, but with reductions in bacterial growth
of 45% (p < 0.05). In five other strains, the growth rates were
reduced by different bacteriophages, and the growth of five strains
was not affected by the bacteriophages. Concerning multidrug-
resistant P. aeruginosa, the bacteriophages promoted alteration
in growth rates in one of the two strains. vB_PaeM_USP_1
and vB_PaeM_USP_3 promoted the greatest growth reductions
(Supplementary Tables 1–5).
Anti-biofilm Activity Measurement
All five bacteriophages reduced the biofilm viability rates in
12 strains (p < 0.05) in about 10-fold CFU/cm2 (Figure 5B).
vB_PaeM_USP_2 and vB_PaeM_USP_18 presented increased
anti-biofilm activity against two multidrug-resistant strains.
Concerning the metabolic activity (XTT), after treatment
of the bacteriophages, the absorbance values reduced in about
50% in 11 strains (p < 0.05; Figure 5B). Bacteriophage
vB_PaeM_USP_2 was able to significantly reduce the metabolic
activity. The mean and the standard deviation values (CFU/cm2
and XTT) after exposure to different bacteriophages are shown in
the supplementary data (Supplementary Tables 6, 7).
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FIGURE 3 | Genome map of the five sequenced bacteriophages depicting the predicted open reading frames colored according to their predicted function (black for
hypothetical proteins, green for genes involved in DNA replication and transcription, blue for DNA packaging and morphogenesis genes, and red for cell lysis genes).
The blue line represents the guanine-cytosine content (%).
FIGURE 4 | Whole genome alignment (using progressive Mauve algorithm) of the bacteriophage genomes demonstrating the high identity between the two groups.
(A) Mauve alignment of the group containing bacteriophages vB_PaeM_USP_1, vB_PaeM_USP_2, and vB_PaeM_USP_3. (B) Mauve alignment of the group
containing bacteriophages vB_PaeM_USP_18 and vB_PaeM_USP_25.
Results from SEM micrographs showed densely associated
bacteria in the control biofilm (Figure 5C). In contrast, after
exposure to bacteriophages, it is possible to observe disrupted
biofilms and cell debris, demonstrating remarkable biofilm
reduction (Figures 5D–H).
DISCUSSION
This study comprises the isolation and the full characterization
of five new P. aeruginosa bacteriophages isolated from domestic
sewage. The bacteriophages showed a broad lytic spectrum, able
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FIGURE 5 | (A) Optical density of planktonic Pseudomonas aeruginosa strains after 2, 4, 6, 8, and 24 h of co-incubation with different bacteriophages.
(B) Anti-biofilm activity of different bacteriophages on biofilm viability rates expressed in log10 CFU/cm2 (left y axis) and metabolic activity expressed in absorbance at
492 nm (right y axis). Inhibition of planktonic growth and anti-biofilm activity assays was carried out at three independent times in triplicate against 15 strains of
P. aeruginosa. (C–H) Scanning electron micrographs after phage treatment: (C) control, (D) vB_PaeM_USP_1, (E) vB_PaeM_USP_2, (F) vB_PaeM_USP_3, (G)
vB_PaeM_USP_18, and (H) vB_PaeM_USP_25. Scale bar = 100 nm. After the treatment of bacteriophages, it is possible to observe lower planktonic growth,
biofilm viability rates, and metabolic activity. Disrupted biofilms and cell debris are also noticed in SEM images.
to disrupt P. aeruginosa biofilms on endotracheal tube surfaces.
Based on the results, the null hypothesis was rejected since there
was a statistical difference on planktonic bacteria growth, viability
rates, and metabolic activity of the biofilm.
The vast majority of the already characterized bacteriophages
are tailed (Hatfull and Hendrix, 2011). Through morphological
and genomics analysis, here there is evidence that all the
five bacteriophages have similar features, belonging to the
order Caudovirales and Myoviridae family. Moreover, genome
sequencing revealed that vB_PaeM_USP_1, vB_PaeM_USP_2,
and vB_PaeM_USP_3 were most closely related to Epa22,
sharing about 96% of identity. Their genomes are typically
organized in clusters. Both guanine-cytosine content and
genome length were similar to other Pbunaviruses as previously
reported (de Melo et al., 2019; Yuan et al., 2019). Regarding
vB_PaeM_USP_18 and vB_PaeM_USP_25, only ca. 20% of their
genomes could be aligned with other phage genomes deposited
at the NCBI. This low identity with other known genomes
does not allow grouping these two phages with any known
genus or subfamily. The inability to group these two genomes
suggests that they belong to a new bacteriophage genus. Genomic
bioinformatics analysis allowed identifying the endolysin gene
on all bacteriophages. Commonly, this enzyme is responsible for
the lytic ability of tailed bacteriophages (Wu et al., 2019). In
addition, several open reading frames could only be annotated
as coding for hypothetical proteins and thus with an unknown
function, something that is common in bacteriophage studies
(Guo et al., 2019).
The one-step growth curve analysis revealed that the latent
period was similar in the five bacteriophages (about 30 min;
Figure 1H), with a progeny per infected cell varying from 22
to 46 bacteriophage particles. Regarding the latent period, the
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same result was reported previously. Nonetheless, comparing
burst sizes with bacteriophages with a similar genome, we noticed
that all bacteriophages produced lower burst sizes (Guo et al.,
2019; Yuan et al., 2019). The reduction observed here could
be explained by differences in bacterial growth rates since the
burst size increases linearly with bacterial growth rate (Nabergoj
et al., 2018). Adsorption and latent period also vary with bacterial
growth rate, decreasing at higher growth rates.
The infectivity of the bacteriophages remained stable for a
pH range from 5.0 to 9.0 and temperature range from 37 to
60◦C (Figure 2). Although pH and temperature do not undergo
abrupt variation in physiological systems, comprehending this
aspect is important in order to maintain bacteriophage viability
and infectivity. Even though new antimicrobial agents should
be investigated, the large pH and temperature tolerance indicate
a broad workability range to search and apply bacteriophage-
based products to setups of different infection models. For
instance, skin becomes more alkaline by bacterial colonization,
and wounds show pH variations in relation to healthy skin
(Schneider et al., 2007).
The lytic activity of bacteriophages was tested against 37
strains (33 P. aeruginosa and four different bacterial species).
Our results reveal that all bacteriophages could efficiently lyse
69.7% of the P. aeruginosa strains, of which seven were multidrug
resistant. Infection of multidrug-resistant P. aeruginosa indicates
that bacteriophages or bacteriophage-based products could
potentially be applied for therapeutic purposes. The lytic rates
presented here are higher than in other Pbunavirus (de Melo
et al., 2019), which can be related to the origin and the number
of tested strains. In fact, host broad range and species specificity
are desirable for bacteriophage application in phage therapy.
Moreover, bacteriophages should be strictly lytic in order to
avoid the risk of potential transmission of virulent bacterial
genes (Canchaya et al., 2003). Here five lytic bacteriophages had
promising results in disrupting mature P. aeruginosa biofilms and
can be further explored in studies involving phage therapy.
Efficiency of plating assays indicated a considerable variation
from low to high between the different bacteriophages on the
different strains. Moreover, the bacteriophages showed inefficient
EOP for six strains. Differences in EOP and absence of lysis can
be explained by the recognition process, which can diverge in
different strains according to the expression of bacteriophage
receptors on the bacterial outer membrane (Uchiyama et al.,
2016). Furthermore, the localization, volume, and density of
surface molecules can affect bacteriophage adsorption (Rakhuba
et al., 2010). Considering the mentioned variation in molecules
for bacteriophage adsorption, the application of a bacteriophage
cocktail, which retains distinct adsorption mechanisms, is
important to maintain bacteriophage infectivity (Forti et al.,
2018). Apart from the recognition process, well-known bacterial
resistance systems against bacteriophages could have led to low
EOP values. Literature has pointed out that many antiviral
mechanisms may be employed by the host cell to evade infection
from bacteriophages, such as restriction nucleases and CRISPR
(Seed, 2015).
Assessing the efficacy of bacteriophages in reducing
P. aeruginosa growth in planktonic form, we observed significant
reductions for up to 8 h of co-incubation for almost all
investigated strains. However, following 24 h of co-incubation,
only three strains showed reduced growth rates. Two multidrug-
resistant P. aeruginosa did not show reduced growth rates at
the evaluated times. Guo et al. (2019) demonstrated that two
new phages at low MOI (0.01) had good performance both
on preventing biofilm formation and eradicating preformed
biofilms. Moreover, Melo et al. (2014), using a MOI of 0.05,
demonstrated reduction in the optical density of planktonic
cells in about 83% of clinical isolates after 24 h of infection.
We considered that antiviral mechanisms might result in the
emergence of bacteriophage-insensitive bacterial strains through
blocking of bacteriophage receptors, production of extracellular
matrix, production of competitive inhibitors, prevention of
bacteriophage DNA entry, slicing of bacteriophage nucleic acids,
and abortive infection mechanisms (Labrie et al., 2010).
We observed a great reduction in planktonic growth and anti-
biofilm activity after treatment of bacteriophages, and it was
widely coincident in both assays. Slight differences were detected
among the strains, which can be related to distinct analysis
methods. Planktonic assays were performed by OD, while anti-
biofilm activity was evaluated by CFU counts and activity
metabolic measurement. Comparing OD and CFU results, only
one strain showed a discordant outcome. Considering the
three analysis methods (OD, CFU, and XTT), the results of
six strains did not seem to be concordant. The lytic activity
of the bacteriophages was relevant to biofilm control on the
endotracheal tube surface. Although no depolymerase was
identified in these bacteriophage genomes, the anti-biofilm action
could be related to the penetration of viruses at the deeper layers
of the biofilm by means of the degradation of the polysaccharide
matrix (Lin et al., 2017).
Anti-biofilm results support the hypothesis that
bacteriophages might be applied as a biocontrol tool against
multidrug-resistant P. aeruginosa on the endotracheal tube
surface in the near future. Systemic treatment with antibiotics
did not fully inhibit biofilm development on endotracheal
tube surfaces (Fernández-Barat et al., 2012). Therefore,
direct administration of non-antibiotic approaches, such as
antimicrobial agents (Guillon et al., 2018) and bacteriophages,
seem to be a suitable option for the fight against persistent
biofilms. Indeed bacteriophages could be potentially applied
on endotracheal tube biofilm as prophylactic and therapeutic
agent. Bacteriophage-coated tubes could be attended to inhibit
bacterial adhesion, whereas direct application may be useful in
reducing microbial bioburden. Aleshkin et al. (2016) reported
the intragastric administration of a phage cocktail in patients
on mechanical ventilation, aiming for the treatment of acute
infections caused by nosocomial pathogens. The authors
demonstrated an important reduction in bacterial counts
after phage therapy, indicating it as an alternative purpose to
antibiotics to treat healthcare-associated infections.
Literature has presented that bacteriophages or the synergistic
action of bacteriophage and antibiotics constitute promising
strategies against multidrug-resistant P. aeruginosa biofilm
(Akturk et al., 2019; Adnan et al., 2020). Given the ability of
new lytic bacteriophages to disrupt and reduce the microbial
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load of endotracheal-associated biofilms in vitro, several aspects
must be taken into consideration before the transfer of phage
therapy to clinical practice. As the device is not in contact
with vascularized tissues, potential bacteriophage administration
routes should be discussed. Moreover, in clinical settings, it is
highly unlikely that the endotracheal tubes will continuously be
exposed to the phages, as demonstrated in this in vitro study.
Thus, we suggest that phage therapy could be applied during
endotracheal suctioning, as recommended for ventilated patients.
The instillation of bacteriophages during the aspiration of
pulmonary secretions could favor its direct application (Guillon
et al., 2018). Inhalation of aerosol-containing antibiotics and
phage formulations is another potential administration route.
In addition, it should be considered that in vivo biofilms are
different from the in vitro ones studied here, probably due to
the presence of body fluids, host cells, and different interactions
among microorganisms. In light of the aforementioned
assumptions, future investigations considering mixed biofilm
models and the synergistic action of phage and antibiotic therapy
should be conducted. Although treatment of bacteriophage
reduced the concentration of P. aeruginosa both on planktonic
and biofilm forms, further research is required to determine
the correct concentration and the possible combinations of
different bacteriophages to establish a cocktail. Based on EOP
and anti-biofilm activity and considering the similarities among
the five bacteriophages, we suggest that, in further studies, a
cocktail composed of vB_PaeM_USP_2 and vB_PaeM_USP_18
should be used. Moreover, only one administration with a single
bacteriophage concentration to treat biofilms was evaluated.
Assessing different times of infection, a strong lytic activity
could be evidenced. In addition, special attention should be
paid to the potential development of bacteriophage resistance.
In view of this, we also consider it necessary to evaluate the
phenotype of bacteriophage-insensitive mutants after a long
exposure to bacteriophages.
CONCLUSION
Biofilms associated with endotracheal tubes are critical concerns
in the development of VAP. Since antibiotic therapy is not
profitable to eliminate biofilms on the surface of medical devices,
bacteriophage therapy offers a possible alternative to reduce
bacterial colonization on the surface of endotracheal tubes. The
studied bacteriophages were efficient in controlling the growth of
P. aeruginosa and promoted biofilm disruption on the surface of
endotracheal tubes, including multidrug-resistant strains. Thus,
they might be considered as good candidates for therapeutic
studies and the application of bacteriophage-encoded proteins.
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